The 2009 pandemic of influenza A virus subtype H1N1 (A[H1N1]pdm09) infection emerged in North America and was first documented in the United States in April 2009 [1] . Monitoring the incidence and clinical characteristics of influenza-related hospitalizations during the pandemic was important in understanding the influenza disease burden, guiding treatment strategies, and measuring impact of prevention programs.
Several published international studies have reported pandemic-associated hospitalization rates on the basis of population-based surveillance data [2] [3] [4] [5] [6] [7] [8] . During typical influenza seasons, young children and elderly individuals experience the highest rates of influenza-related hospitalization. However, the majority of studies conducted in the northern and southern hemispheres during the pandemic have reported a high burden of disease among children and younger adults and a lower than expected disease burden among elderly individuals [9] .
Studies conducted in the United States have described characteristics of children and adults hospitalized during the pandemic [10] [11] [12] [13] [14] [15] . Two of these studies, conducted in individual states, reported on pandemic-associated hospitalization rates [14, 15] . However, no studies to date have described pandemic-associated hospitalization rates among children and adults on the basis of a sample of the US population.
Since 2003, the Centers for Disease Control and Prevention (CDC) Emerging Infections Programs (EIP) network has conducted population-based surveillance for laboratoryconfirmed, influenza-associated hospitalization among children. In 2005, surveillance was expanded to include adults. We used data collected during the pandemic to describe clinical characteristics of hospitalized children and adults, to calculate hospitalization rates during the pandemic period, and to compare rates with those from previous years during which the EIP conducted surveillance.
METHODS
The EIP is a collaboration of state and local health departments, academic institutions, medical communities, and the CDC that conducts population-based surveillance in a geographically diverse catchment area of the United States [16] . The EIP surveillance area has been previously described [17, 18] . During the 2009-2010 influenza season, the surveillance area encompassed parts of 10 states. A total of 5.3 million children aged <18 years and 16.8 million adults aged ≥18 years, representing 7% of the US population, resided in the surveillance area.
Case Definition
A case was defined as a child (ie, an individual aged <18 years) or adult (ie, an individual aged ≥18 years) resident of the catchment area who was hospitalized with communityacquired influenza during 15 April 2009-30 April 2010 (a period inclusive of both waves of A[H1N1]pdm09 spread) and who had an influenza virus-positive diagnostic test ≤14 days before or ≤3 days after hospital admission.
Laboratory confirmation of influenza virus infection was determined by viral culture, immunofluorescence antibody staining, reverse-transcription polymerase chain reaction (RT-PCR), commercially available rapid diagnostic test, or documentation of a positive test result in the patient's medical record. EIP staff identified cases by contacting hospital laboratories, medical records departments, and infection control practitioners and by reviewing databases of state-reportable conditions.
We limited our analysis to include only individuals with either confirmed or probable A(H1N1)pdm09 infection. Individuals were considered to have probable A(H1N1)pdm09 infection if they were hospitalized with unsubtyped influenza A virus infection between 1 June 2009 and 30 April 2010, a period during which A(H1N1)pdm09 composed nearly all circulating influenza viruses. Individuals with unsubtyped influenza A virus infection prior to 1 June 2009 or confirmed seasonal influenza virus infection were excluded from the analysis.
Data Collection
A standardized case report form was completed by EIP staff who abstracted information from the medical records of hospitalized patients meeting the case definition. Data on complications during hospitalization, such as pneumonia or bacterial coinfection, were collected and recorded on the standardized case report form. Classification of pneumonia was performed using narrative information from the hospital discharge summary. Bacterial coinfection was defined as growth of a bacterial pathogen from a normally sterile site (ie, blood, cerebrospinal fluid, pleural fluid, or a tissue specimen) within 3 days of hospital admission. Decisions regarding procurement of bacterial cultures were made by the treating clinician. Coagulase-negative staphylococcus species were considered pathogens only when isolated from a cerebrospinal fluid culture, from an immunosuppressed patient, or from a neonate aged <28 days.
The influenza vaccination status of each individual who met the case definition was determined by reviewing their medical record, consulting the appropriate immunization registry, contacting their primary care provider, or contacting their patient/guardian. Children and adults were considered vaccinated against A(H1N1)pdm09 infection or seasonal influenza virus infection if they had received at least 1 dose of the respective vaccine at least 14 days prior to hospitalization. For analysis of A(H1N1)pdm09 vaccination, we limited our evaluation to those who were hospitalized on or after 1 January 2010, by which time the A(H1N1)pdm09 vaccine had become widely available [19] .
Human Subjects Review
Collection of pediatric data at EIP sites has been determined by the CDC to be routine public health surveillance and as such was not subject to institutional review board (IRB) approval for human research protections. For adult data, starting with the 2006-2007 season, research questions were added to evaluate factors that might provide protection against severe outcomes during hospitalization. Accordingly, IRB approval for collection of adult data was obtained from all sites, including the CDC.
Analysis
Pediatric and adult hospitalization rates were calculated using 2009 vintage population estimates from the National Center for Health Statistics. The hospitalization rate denominator for children aged <6 months was estimated to be half of the population of children aged <1 year living in the surveillance area. Because the study period was approximately 54 weeks in duration, calculated rates were adjusted to reflect a 52-week period. 
RESULTS

Overall
During the 2009-2010 pandemic, 7942 hospitalizations due to confirmed influenza were identified in the EIP catchment area. Of these, 100 were due to confirmed seasonal influenza virus infections, and 125 were due to untyped influenza virus infections or unsubtyped influenza A virus infections identified prior to 1 June 2009; these 225 episodes were thus excluded from the analysis. Of the 7717 remaining hospitalizations, 2479 involved children, and 5238 involved adults ( Table 1) .
The overall rate of pediatric influenza-associated hospitalizations during the 2009-2010 pandemic was 44 episodes per 100 000 population, with an adult hospitalization rate of 29 episodes per 100 000 ( Table 1 ). The highest rates of hospitalization occurred among children aged <5 years, with particularly high rates among infants aged <6 months (202 episodes per 100 000) and children aged 6-23 months (88 episodes per 100 000). The lowest rates of hospitalization occurred among adults aged 18-49 years (27 episodes per 100 000) and adults aged ≥75 years (27 episodes per 100 000).
In comparison, during the 6 influenza seasons preceding the pandemic during which the EIP conducted surveillance for pediatric hospitalizations, the mean pediatric hospitalization rate for laboratory-confirmed infection was 16 episodes per 100 000, with age-specific mean rates of 153, 53, 20, and 6 episodes per 100 000 for children aged <6 months, 6-23 months, 2-4 years, and 5-17 years, respectively ( Table 2 ). In the 4 influenza seasons prior to the pandemic during which the EIP conducted surveillance for adult hospitalizations, the mean adult hospitalization rate was 10 episodes per 100 000, with age-specific mean rates of 4, 8, 20, and 56 episodes per 100 000 for adults aged 18-49 years, 50-64 years, 65-74 years, and ≥75 years, respectively. Prior to the 2009 pandemic, the highest EIP-documented pediatric and adult hospitalization rates for a single season were 30 and 19 episodes per 100 000 children and adults, respectively [17, 18] .
Similar to other epidemiologic data, we observed 2 distinct waves of influenza activity: a small first wave in the spring and c School-aged children (aged 5-17 years) constituted a significantly larger proportion of hospitalizations during the first wave of disease, compared with the second wave (22% vs 15%; P < .001).
summer months and a much larger second wave during the fall ( Figure 1 ). We analyzed the proportion of hospitalizations among each age group during the first and second waves, defined by the intervals 15 April-31 July 2009 and 1 August 2009-30 April 2010, respectively. We found that school-aged children (ie, individuals aged 5-17 years) constituted a significantly larger proportion of hospitalizations during the first wave of disease, compared with the second wave (22% vs 15%; P < .001) ( Table 1) .
Children
Of the 2479 children hospitalized during the study period, 58% were male, 34% were white, 25% were black, and 25% were Hispanic (Table 3) . RT-PCR was the most common method of influenza diagnostic testing (72%). Fifty-seven percent of hospitalized children had an underlying medical condition, the most common of which was asthma (32%), followed by developmental delay (8%), seizure disorder (5%), and neuromuscular disorder (5%) ( Table 4) . Among children, complications included pneumonia (33%), bronchiolitis (6%), seizures (4%), and invasive bacterial coinfection (2%). Of the 49 pediatric cases of bacterial coinfection, Streptococcus pneumoniae was the most commonly isolated pathogen (43%), followed by Staphylococcus aureus (29%). A total of 451 children (18%) were hospitalized in the intensive care unit, 139 (6%) required mechanical ventilation, and 24 (1%) died. Of the 24 pediatric deaths, 20 (83%) involved an underlying medical condition. Of 1285 children with positive results of diagnostic tests within 2 days of symptom onset, 1083 (84%) received antiviral treatment (Table 3) . Of 115 children hospitalized on or after 1 January 2010, 32 (28%) had received ≥1 dose of the A(H1N1)pdm09 vaccine. 
Adults
Of the 5238 adults hospitalized during the study period, 42% were male, 44% were white, 24% were black, and 15% were Hispanic (Table 3) . RT-PCR was the most common method of influenza diagnostic testing (80%). Eighty-three percent of adults had an underlying medical condition, the most common of which was asthma (30%), followed by chronic metabolic disease (27%) and cardiovascular disease (19%) ( Table 4) . Among adults, complications included pneumonia (40%) and invasive bacterial coinfection (3%). Of the 165 adult cases of bacterial coinfection, S. pneumoniae was the most commonly isolated pathogen (35%), followed by S. aureus (25%). Among adults, 1196 (23%) were hospitalized in the intensive care unit, 658 (13%) required mechanical ventilation, and 201 (4%) died. Of the 201 adult deaths, 169 (84%) involved an underlying medical condition. Eighty-two percent of all hospitalized adults received antiviral treatment (Table 3) . Of the 325 adults hospitalized on or after 1 January 2010, 29 (9%) had received the A(H1N1)pdm09 vaccine.
DISCUSSION
Rates of hospitalization for laboratory-confirmed influenza among children and the majority of adults were greatly increased during the pandemic, compared with rates calculated using data aggregated from all previous influenza seasons during which the EIP conducted surveillance (Table 2 ). In particular, school-aged children aged 5-17 years and adults aged 18-49 years had substantially elevated rates, compared with previous influenza seasons, while adults aged ≥75 years had dramatically lower rates. Epidemiologic data from the United States indicate that children experienced the highest overall attack rates during the pandemic [20] [21] [22] . Consistent with previous influenza seasons, infants aged <6 months and toddlers aged 6-23 months experienced the highest rates of hospitalization during the pandemic. Pandemic rates among children aged <2 years were higher than rates during all previous influenza seasons except the 2003-2004 season, during which a particularly virulent group of H3N2 viruses composed >99% of all circulating influenza virus strains, causing significant morbidity and mortality among younger children [23] .
Among pediatric age groups, school-aged children (age range, 5-17 years) appeared to be disproportionately affected, experiencing a 5-fold increase in hospitalization rates during the pandemic, compared with previous influenza seasons. We found that school-aged children constituted a significantly larger proportion of hospitalizations during the first wave of disease, compared with the second wave, indicating early spread among individuals in this age group (Table 1) . This finding is consistent with other studies in North America that evaluated demographic characteristics of hospitalized individuals during the first and second wave of the pandemic [15, 24] .
Adults aged 18-49 years experienced a 6-fold increase in the pandemic-associated hospitalization rate, compared with the average from 4 previous influenza seasons, while adults aged 50-64 years had a 5-fold increase. Adults aged ≥75 years experienced a substantially lower rate of influenza-related hospitalization, compared with previous seasons. Serosurveys conducted in the United States using serum specimens drawn prior to the pandemic indicated that a large proportion of older adults had preexisting cross-reactive antibodies to A (H1N1)pdm09 [25] . These antibodies are thought to have provided immune protection among elderly individuals, rendering them less susceptible to A(H1N1)pdm09 infection. Epidemiologic data collected during the pandemic indicate that elderly individuals experienced lower attack rates, compared with previous influenza seasons [26, 27] ; however, the proportion of infected adults who required hospitalization and the prevalence of complications among those who were hospitalized were similar to values from previous years [17] .
A larger proportion of children hospitalized during the pandemic had an underlying medical condition, compared with aggregated data from previous influenza seasons (57% vs 47%; P < .001) [18] . In particular, the proportion of children with a diagnosis of asthma nearly doubled, from 18% of hospitalizations during the 2003-2008 influenza seasons to 32% during the pandemic, suggesting an increased predisposition toward severe disease in this group. Other studies conducted during the pandemic have shown that asthmatic patients composed a similarly high percentage of overall hospitalizations [10, 11, 13] . Persons with asthma are known to be at a higher risk for viral respiratory infections [28] [29] [30] ; however, the reason for this increase in the proportion of patients with a diagnosis of asthma is unclear.
Although the proportion of hospitalized children and adults with an invasive bacterial infection was similar to the proportions in previous influenza seasons, there was an unusual shift in the distribution of invasive pathogens. Whereas S. aureus was the predominant pathogen isolated from both children and adults during previous influenza seasons, S. pneumoniae was the most commonly isolated pathogen during the pandemic [17, 18] . Several studies both prior to and during the pandemic have reported on the association between influenza and pneumococcal disease [31] [32] [33] [34] [35] [36] [37] . Further investigation is needed to better understand this shift in influenza-associated pathogens that was observed during the pandemic.
A larger proportion of children hospitalized during the pandemic died, compared with children hospitalized during previous influenza seasons (1.0% vs 0.4%). A substantial proportion of deaths among both children and adults involved individuals with an underlying medical condition, accentuating the need to strengthen prevention efforts in this at-risk population.
Vaccine for A(H1N1)pdm09 did not become widely available in the United States until the late fall because of delays in vaccine production [19] . When we limited our analysis of A (H1N1)pdm09 vaccination to individuals who were hospitalized on or after 1 January 2010, we found that a much larger proportion of hospitalized children had been vaccinated, compared with adults. This finding may be related to several factors, including the selection of children as a primary target group for A(H1N1)pdm09 vaccination. Vaccination remains the primary tool in preventing influenza and its complications, including hospitalization. In 2010, the CDC Advisory Committee on Immunization Practices (ACIP) expanded vaccination recommendations to include all adults and children aged ≥6 months [38] . To prevent influenza and its complications, healthcare professionals should provide a strong recommendation for annual influenza vaccination.
A dramatic increase in antiviral treatment of hospitalized patients was observed during the pandemic. [18] . Continued efforts are necessary to ensure that patients hospitalized during subsequent influenza seasons receive early treatment with antiviral agents.
Rapid influenza diagnostic tests (RIDTs) were much more commonly used during previous influenza seasons, whereas RT-PCR was the most common diagnostic test used during the pandemic. The proportion of children who received a diagnosis on the basis of RT-PCR analysis increased from 1%-5% during the influenza seasons from 2003-2004 through 2007-2008 to 72% during the pandemic [18] . Among adults, a corresponding increase was seen in RT-PCR use, from 5%-6% of cases during the seasons from 2005-2006 through 2007-2008 to 80% during the pandemic [17] . The sensitivity of RT-PCR is much higher than that of RIDTs, whereas both tests have a very high specificity. A recent meta-analysis of RIDT performance reported a combined RIDT sensitivity of 62%-72% among children and 48%-60% among adults, compared with either viral culture or RT-PCR [39] . On the basis of the testing methods used both during and prior to the pandemic and the sensitivity of each method, we estimate that 15%-30% more influenza-associated hospitalizations would have been identified among children in the prepandemic period if RT-PCR was used to the same extent as during the pandemic. For adults, we estimate that 30%-55% more influenza-associated hospitalizations would have been identified in the prepandemic period. It is possible that, for children aged <6 months and adults aged 65-74 years, the modest differences between rates during the pandemic and mean rates during previous seasons may be due to changes in testing methods used during each interval. However, for all other age groups, the observed differences in hospitalization rates are too large to be explained solely by the increased use of RT-PCR during the pandemic. Furthermore, for adults aged ≥75 years, who experienced lower hospitalization rates during the pandemic as compared to previous influenza seasons, this shift to increased use of RT-PCR during the pandemic accentuates the observed decrease in hospitalization rates during the pandemic.
Our findings of elevated hospitalization rates among children and young adults with a decreased rate of disease among elderly individuals are comparable to previously published studies from the United States and other areas of the world [7] [8] [9] 40] . A global pooled analysis of pandemic-associated hospitalizations from countries in the northern and southern hemispheres found the highest per capita risk of hospitalization among children aged <5 years, with the lowest risk among adults, including elderly individuals [9] . Furthermore, studies with access to prepandemic hospitalization data have reported a substantial increase in hospitalization rates among school-aged children [4, 41] . Few studies have had access to prepandemic surveillance data among adults necessary to compare pandemic rates with historic trends. Our report of a 6-fold increase in hospitalization rates among younger adults aged 18-49 years provides a unique insight into the effects of the pandemic on this age group. Finally, one of the most striking consistencies in the published literature is the relatively low burden of disease reported among elderly individuals, a demographic group historically vulnerable to influenza virus infection [7] [8] [9] . These reports correspond to our findings of a pandemic-associated hospitalization rate among this age group that was roughly half that observed during previous influenza seasons.
Our results are subject to several limitations. First, because EIP surveillance requires laboratory confirmation of influenza, it usually underestimates true hospitalization rates. Second, healthcare professionals may have been more likely to test hospitalized patients for influenza during the pandemic than in previous influenza seasons, leading to an increase in the number of identified cases. Third, because of the increased use of more-sensitive testing modalities (ie RT-PCR), it is likely that an increased number of cases may have been detected during the pandemic, compared with previous influenza seasons, although this would not account for the vast differences in hospitalization rates observed in most age groups. Finally, EIP pandemic-associated hospitalization rates are based on a 12-month period of surveillance, whereas rates during previous influenza seasons are based on hospitalizations occurring from 1 October through 30 April, annualized over 1 calendar year, thereby limiting direct comparison.
However, virologic data indicate that, during typical influenza seasons, circulation of influenza virus is minimal during the late spring and summer months; thus, any underestimation of seasonal influenza-associated hospitalization rates is likely minimal. Despite these limitations, our findings provide useful information and are comparable with results from other studies incorporating different surveillance methods [40, 42] .
As a result of having initiated surveillance several years prior to the pandemic, the EIP was uniquely positioned to provide data allowing for direct comparison of pandemic and seasonal influenza hospitalizations. By using EIP data, we found evidence of a shift in disease burden when comparing pandemicassociated hospitalization rates to previous influenza seasons, including higher rates of hospitalization among school-aged children and younger adults and a lower rate among elderly individuals. Our results highlight the importance of surveillance in identifying risk factors for influenza hospitalization, monitoring adherence to influenza prevention and treatment strategies, and evaluating the disease burden during pandemic periods, as well as during annual influenza seasons.
Notes
